HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Le, Y. Articles by Wang, J. M. Search for Related Content PubMed PubMed Citation Articles by Le, Y. Articles by Wang, J. M.

TGF-1 Disrupts Endotoxin Signaling in Microglial Cells through Smad3 and MAPK Pathways^1,2

Yingying Le^*, Pablo Iribarren^*, Wanghua Gong, Youhong Cui^*, Xia Zhang and Ji Ming Wang^3,*

Laboratories of ^* Molecular Immunoregulation and Experimental Immunology, Center for Cancer Research, and Basic Research Program, Science Applications International Corporation-Frederick, National Cancer Institute-Frederick, Frederick, MD 21702

Human formyl peptide receptor-like 1 and its mouse homologue formyl peptide receptor 2 (FPR2) are G protein-coupled receptors used by a number of exogenous and host-derived chemotactic peptides, including the 42 aa form of amyloid peptide, a causative factor of Alzheimer’s disease. Functional FPR2 was induced by bacterial LPS in murine microglial cells, the resident phagocytic cells that play a pivotal role in inflammatory and immunological diseases in the CNS. To identify agents that may suppress microglial cell activation under proinflammatory conditions, we investigated the effect of TGF-1 on the expression of functional FPR2 by microglial cells activated by LPS. TGF-1 dose-dependently inhibited the mRNA expression and function of FPR2 in LPS-activated microglial cells. The inhibitory effect of TGF-1 was mediated by Smad3, a key signaling molecule coupled to the TGF- receptor, and the transcription coactivator, p300. Also, TGF-1 activates MAPKs in microglial cells that became refractory to further stimulation by LPS. These effects of TGF-1 culminate in the inhibition of LPS-induced activation of NF-B and the up-regulation of FPR2 in microglial cells. Thus, TGF-1 may exert a protective role in CNS diseases characterized by microglial cell activation by proinflammatory stimulants.

This article has been cited by other articles:

				S. Matsumura, T. Shibakusa, T. Fujikawa, H. Yamada, K. Matsumura, K. Inoue, and T. Fushiki Intracisternal administration of transforming growth factor- evokes fever through the induction of cyclooxygenase-2 in brain endothelial cells Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R266 - R275. [Abstract] [Full Text] [PDF]

				M. A. Bausero, R. Gastpar, G. Multhoff, and A. Asea Alternative Mechanism by which IFN-{gamma} Enhances Tumor Recognition: Active Release of Heat Shock Protein 72 J. Immunol., September 1, 2005; 175(5): 2900 - 2912. [Abstract] [Full Text] [PDF]